胜肽合成市場規模、佔有率、成長分析、按產品、按技術、按應用、按最終用途、按地區 - 產業預測，2024-2031年

2022年全球胜肽合成市場規模為6.1956億美元，預計預測期內（2024-2031年）年複合成長率為13.0%，從2023年的7.11億美元成長到2031年的18.612億美元。

由於對肽類療法的需求不斷增加，全球肽合成市場顯著成長。胜肽作為控制各種生理功能和代謝過程的訊號分子，與傳統的小分子藥物和生技藥品相比，具有改善的代謝穩定性、高靶點特異性和強結合親和性，近年來受到人們的關注。特別是，全球已有80多種胜肽療法已被核准用於治療癌症、糖尿病和愛滋病毒等慢性疾病，並且自2015年以來已經進行了630多項臨床試驗來評估其治療效果。基於胜肽的診斷和治療劑的激增，尤其是在大流行之後，反映出人們對胜肽合成作為現代醫學的重要組成部分日益成長的興趣。

目錄

介紹

• 研究目的
• 調查範圍
• 定義

調查方法

• 資訊採購
• 二手資料和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 依細分市場的機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制因素和挑戰
• 波特分析及影響
  • 競爭公司之間的敵對關係
  • 替代品的威脅
  • 買方議價能力
  • 新進入者的威脅
  • 供應商的議價能力

主要市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 技術進步
• 監管環境
• 專利分析
• 價值鏈分析
• 案例研究分析

全球胜肽合成市場規模：依產品/服務，年複合成長率（2024-2031）

• 試劑
  • 樹脂
  • 胺基酸
  • 耦合試劑
  • 染料/螢光標記試劑
  • 其他試劑
• 裝置
  • 胜肽合成儀
  • 層析法設備
  • 冷凍乾燥機
• 服務

胜肽合成市場規模：依技術，年複合成長率（2024-2031）

• 固相胜肽合成
• 液相胜肽合成
• 混合/重組技術

胜肽合成市場規模：依最終用戶，年複合成長率（2024-2031）

• 製藥和生物技術公司
• CDMO,CRO
• 學術/研究機構

胜肽合成市場規模，年複合成長率（2024-2031）

• 北美（產品/服務，技術，最終用戶）
  • 美國
  • 加拿大
• 歐洲（產品/服務，技術，最終用戶）
  • 英國
  • 德國
  • 西班牙
  • 法國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區（產品/服務，技術，最終用戶）
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲（產品/服務，技術，最終用戶）
  • 巴西
  • 其他拉丁美洲地區
• 中東、非洲（產品/服務，技術，最終用戶）
  • 海灣合作理事會國家
  • 南非
  • 其他中東、非洲

競爭資訊

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2023）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 依公司分類的佔有率分析
  • 收益與前一年同期比較（2021-2023）

主要企業簡介

• MERCK KGAA
• THERMO FISHER SCIENTIFIC
• GENSCRIPT BIOTECH CORPORATION
• BACHEM HOLDING AG
• KANEKA CORPORATION
• BIOTAGE AB
• SYNGENE INTERNATIONAL LIMITED
• MESA LABORATORIES, INC.
• CEM CORPORATION
• PROTEOGENIX
• BIO-SYNTHESIS INC.
• DALTON PHARMA SERVICES
• AAPPTEC
• VIVITIDE
• ANYGEN CO., LTD.
• ADVANCED CHEMTECH
• LUXEMBOURG BIO TECHNOLOGIES LTD.
• JPT PEPTIDE TECHNOLOGIES GMBH
• AMBIOPHARM INC.
• AURIGENE PHARMACEUTICAL SERVICES LTD.

結論和建議

Global Peptide Synthesis Market size was valued at USD 619.56 million in 2022 and is poised to grow from USD 700.11 million in 2023 to USD 1861.20 million by 2031, growing at a CAGR of 13.0% during the forecast period (2024-2031).

The global peptide synthesis market has experienced significant growth driven by the increasing demand for peptide-based therapeutics. Peptides, which act as signaling molecules that regulate various physiological functions and metabolic processes, have gained traction in recent years due to their improved metabolic stability, target specificity, and stronger binding affinity compared to traditional small molecule drugs and biologics. Notably, over 80 peptide therapeutics have been approved globally for treating chronic conditions such as cancer, diabetes, and HIV, with more than 630 clinical trials conducted since 2015 to evaluate their therapeutic efficacy. The surge in peptide-based diagnostics and therapies, especially post-pandemic, reflects growing interest in peptide synthesis as an essential component of modern medicine.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Peptide Synthesis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Peptide Synthesis Market Segmental Analysis

Global Peptide Synthesis Market is segmented by Product & Services, Technology, end user and region. Based on Product & Services, the market is segmented into Reagents, Equipment, Services. Based on Technology, the market is segmented into Solid-Phase Peptide Synthesis, Solution-Phase Peptide Synthesis, Hybrid & Recombinant Technology. Based on end user, the market is segmented into Pharmaceutical & Biotechnology companies, CDMOs & CROs, Academic & Research Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Peptide Synthesis Market

The growing demand for imaging technology to enable accurate diagnosis of chronic diseases is a significant driver for the global peptide synthesis market. Valued at over USD 30 billion in 2023, the peptide synthesis market is benefiting from the increasing use of peptide-based biosensors and biomarkers, both in invasive and non-invasive diagnostic applications. These advanced diagnostic tools are witnessing substantial demand, as they provide critical insights into various health conditions. The rise in healthcare applications for peptide-based biosensors, along with their ability to enhance disease detection and monitoring, is fueling market growth and creating new opportunities for peptide synthesis technologies. This trend is expected to continue driving market expansion in the coming years.

Restraints in the Global Peptide Synthesis Market

A significant restraint in the global peptide synthesis market is the reliance on contract manufacturing organizations (CMOs) for peptide production. Pharmaceutical companies are investing heavily in the development of peptide-based therapeutics, but the manufacturing process is mostly outsourced to CMOs, which are typically located in developed economies due to lower production costs. This reliance on external manufacturers can lead to challenges in maintaining strict adherence to standardization guidelines and safety standards, potentially affecting the consistency and quality of peptide products. Additionally, the limited control over the manufacturing process can introduce risks related to regulatory compliance, further constraining market growth.

Market Trends of the Global Peptide Synthesis Market

A key trend in the global peptide synthesis market is the steady rise in demand from the pharmaceutical industry, driven by increased research and development (R&D) investments. The pharmaceutical sector is witnessing significant growth, with R&D spending growing even faster. According to a 2020 survey by the US Census Bureau, pharmaceutical R&D expenditure has surged by over 25% over the past decade, reflecting a growing commitment to innovation. This trend is enhancing the funding available for the development of advanced peptide synthesis solutions and processes, further driving market growth. The surge in pharmaceutical R&D budgets is expected to continue fostering advancements in peptide synthesis technologies, expanding their applications and market opportunities.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Technological Advancement
• Regulatory Landscape
• Patent Analysis
• Value Chain Analysis
• Case Study Analysis

Global Peptide Synthesis Market Size by Product & Service & CAGR (2024-2031)

• Reagents
  • Resins
  • Amino acids
  • Coupling Reagents
  • Dyes and Fluorescent labeling reagents
  • Other Reagents
• Equipment
  • Peptide Synthesizers
  • Chromatography Equipment
  • Lyophiizers
• Services

Global Peptide Synthesis Market Size by Technology & CAGR (2024-2031)

• Solid-Phase Peptide Synthesis
• Solution-Phase Peptide Synthesis
• Hybrid & Recombinant Technology

Global Peptide Synthesis Market Size by End User & CAGR (2024-2031)

• Pharmaceutical & Biotechnology companies
• CDMOs & CROs
• Academic & Research Institutes

Global Peptide Synthesis Market Size & CAGR (2024-2031)

• North America, (Product & Services, Technology, End User)
  • US
  • Canada
• Europe, (Product & Services, Technology, End User)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific, (Product & Services, Technology, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America, (Product & Services, Technology, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa, (Product & Services, Technology, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• MERCK KGAA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• THERMO FISHER SCIENTIFIC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GENSCRIPT BIOTECH CORPORATION
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BACHEM HOLDING AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• KANEKA CORPORATION
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BIOTAGE AB
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SYNGENE INTERNATIONAL LIMITED
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MESA LABORATORIES, INC.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CEM CORPORATION
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PROTEOGENIX
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BIO-SYNTHESIS INC.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DALTON PHARMA SERVICES
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AAPPTEC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• VIVITIDE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ANYGEN CO., LTD.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ADVANCED CHEMTECH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LUXEMBOURG BIO TECHNOLOGIES LTD.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• JPT PEPTIDE TECHNOLOGIES GMBH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AMBIOPHARM INC.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AURIGENE PHARMACEUTICAL SERVICES LTD.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation